0000950170-24-067666.txt : 20240603
0000950170-24-067666.hdr.sgml : 20240603
20240603083442
ACCESSION NUMBER: 0000950170-24-067666
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240531
FILED AS OF DATE: 20240603
DATE AS OF CHANGE: 20240603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shukla Sanjay
CENTRAL INDEX KEY: 0001671026
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 241012095
MAIL ADDRESS:
STREET 1: C/O ATYR PHARMA, INC.
STREET 2: 10240 SORRENTO VALLEY ROAD, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8587318389
MAIL ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
ownership.xml
4
X0508
4
2024-05-31
0001339970
aTYR PHARMA INC
LIFE
0001671026
Shukla Sanjay
10240 SORRENTO VALLEY ROAD
SUITE 300
SAN DIEGO
CA
92121
true
true
false
false
President and CEO
false
Common Stock
2024-05-31
4
P
false
20000
1.8070
A
136548
D
Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.77 to $1.86 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
/s/ Nancy E. Denyes, as Attorney-in-Fact
2024-06-03